A randomised controlled trial and consumer characteristics of iMindTime eHealth: A comprehensive mindfulness and loving kindness meditation wellbeing online program.

None listed

A randomised controlled trial will be used to investigate the effectiveness of the iMindTime eHealth program. The iMindTime program will be placed within the Federation eHealth Platform. People visiting the website, in response to advertisements or through self interest, will be informed of the availability of the iMindTime program and invited to participate in the study. People who consent to take part in the study will be randomly allocated to either an immediate access to the program, or delayed access (7 week delay). The iMindTime eHealth program consists of six brief sessions, over 3 weeks, designed to make an individual more mindful or increase awareness of moment-to-moment experiences (e.g., thoughts, feelings, sensations) and simply accepting what is there without wanting it to change in any way. Participants will spend three days on each session before moving onto the next session. Each session will require 5-10 minutes to read and its user friendly and interactive components are designed to keep the user engaged. To consolidate learning, participants will be given activities (10-20 minutes per day) to complete offline to practise the principles of specific mindfulness exercises (i.e., mindfulness of the breath, mindfulness of body sensations, mindfulness of emotions, mindfulness of sounds, mindfulness of thoughts and loving kindness meditation) and asked to provide simple feedback on this practise at the next session. Participants will also receive automated emails (e.g., to remind them to log on, when to complete post/follow-up questionnaires) and will be asked several questions during the study period to monitor their progress. Participants randomised to the iMindTime eHealth (immediate access) group will complete a pre-intervention assessment (Week 0), during intervention (Week 2) assessment, post-intervention assessment (Week 4) and a 1 month follow-up assessment (Week 8). Participants randomised to the delayed access group will complete the same assessment phases and will be given access to iMindTime eHealth program following the 1 month follow-up assessment (Week 8). However the delayed access group will be asked to complete the post intervention assessment after they have completed the iMindeHealth program (Week 11). It is expected that people who undertake iMindTime will show increases in mental wellbeing and optimism and reductions in negative affect at post and follow-up time points

No related papers found yet.